Description
ARA-290 – Cytoprotective and Anti-Inflammatory Research Peptide
ARA-290 is a synthetic peptide derived from the erythropoietin (EPO) molecule, specifically engineered to retain EPO’s tissue-protective and anti-inflammatory properties without stimulating erythropoiesis.
It selectively activates the EPOR/CD131 receptor complex, initiating pathways that promote cell survival, tissue repair, and reduction of inflammation in neural and vascular systems.
Preclinical studies highlight ARA-290’s effectiveness in modulating immune responses, improving nerve regeneration, and reducing pain sensitivity. This makes it a valuable compound for research into neuropathic pain, diabetes-related complications, autoimmune inflammation, and tissue repair.
Key Features & Research Applications
🧠 Neuroprotection:
Supports nerve repair and reduces inflammation in peripheral and central nervous system models.
💉 Anti-Inflammatory Action:
Demonstrates strong modulation of cytokine activity, helping to restore immune balance and reduce chronic inflammation.
🧩 Tissue Regeneration:
Promotes healing and recovery in vascular, renal, and muscular tissues without increasing red blood cell production.
⚡ Pain Modulation:
Investigated for its ability to reduce neuropathic and inflammatory pain by acting on the innate repair receptor (IRR).
🔬 Therapeutic Potential:
Ongoing research explores applications in diabetes-induced neuropathy, autoimmune disorders, and ischemic injury recovery.
Product Details
-
Name: ARA-290
-
Form: Lyophilized powder
-
Molecular Formula: C₁₆₅H₂₅₄N₄₄O₄₆S
-
Molecular Weight: 3741.1 g/mol
-
Purity: ≥ 98% (HPLC verified)
-
Dosage Strength: 10 mg per vial
-
Appearance: White to off-white lyophilized powder
-
Storage: Store in a cool, dry place; refrigerate at 35.6–46.4°F after reconstitution.
-
Packaging: Sterile, airtight vial for research use.
-
Verification: Third-party laboratory tested for purity and authenticity.
